UnitedHealth Group executives also say the measure forbidding simultaneous ownership of pharmacies and PBMs will hurt patients’ access to medicines. Both companies said they will work with lawmakers on possible solutions.
[Sponsored] Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost. The post How to Improve Employee Benefits While Reducing Insurance Costs appeared first on MedCity News.
As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to review and potentially approve such treatments. The post Ouster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions…
KFF’s new analysis examines how state coverage changes and expansions in Medicaid and CHIP eligibility for children may help to bolster coverage following the unwinding of the continuous enrollment provision.
Regenstrief’s Joshua Vest, Ph.D., M.P.H., discusses potential advantages of using a predictive model to predict future need for health-related social services
Union Health is making a new bid to Indiana regulators to buy its rival hospital in Terre Haute as the door looks poised to close on such deals. The nonprofit health system is trying to leverage an existing state law to acquire Terre Haute Regional Hospital, the only other acute care hospital in Vigo County….
Benjamin Han, a geriatrician and addiction medicine specialist at the University of California-San Diego, tells his students a cautionary tale about a 76-year-old patient who, like many older people, struggled with insomnia. “She had problems falling asleep, and she’d wake up in the middle of the night,” he said. “So her daughter brought her some…
In 2011, National Institutes of Health (NIH)-funded discoveries contributed $69 billion to the nation’s gross domestic product (GDP) and supported seven million jobs. In 2020 alone, the US biomedical and pharmaceutical private sector generated more than $1.4 trillion in economic output. From Reece et al. (Health Affairs 2025) In addition to economic output, private-sector R&D…
In this viewpoint article in the Journal of the International AIDS Society, KFF’s Jennifer Kates and co-authors Brian Honermann and Gregorio Millett of amfAR explore the implications of shifts in the global economic and political environment for the future of PEPFAR, the U.S government’s global HIV program created under President George W. Bush and credited…
Repare Therapeutics is cutting discovery and preclinical work to focus on its clinical-stage cancer drugs. The most advanced program is camonsertib, whose rights Repare recently regained from Roche after the pharma giant terminated an alliance started in 2022. The post Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline appeared first on MedCity News.